Serum Uric Acid Level and Cardiovascular Disease Development Risk in Stage 3-5 Chronic Kidney Disease Patients
Yükleniyor...
Dosyalar
Tarih
2020
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Aim: The patients with chronic kidney disease (CKD) have higher risk of cardiovasculardisease (CVD) than the general population and this risk increases in advanced CKD stages.The data about the association between CVD and uric acid level in stage 3-5 CKD patients arelimited in the literature. The aim of this study is to investigate whether uric acid levels areassociated with cardiovascular events and mortality in the CKD patients.Material and Methods: Patients who were followed up with the diagnosis of stage 3-5 CKDbetween June 2014 and December 2019 were evaluated retrospectively. A hundred stage 3-5CKD cases above the age of eighteen were included in the study. The patients were dividedinto two groups according to average serum uric acid levels; <7 mg/dL and ?7 mg/dL. Anyconfirmed diagnosis of stroke, myocardial infarction, coronary heart disease or heart failurewas accepted positive for the history of CVD.Results: Cardiovascular event development was observed in 15 patients and mortality in 1patient. CVD were seen in 10 (21.3%) patients in group 1 while 5 (9.4%) patients in group 2.Although the cardiovascular events were seen more in the group 1, this difference was notstatistically significant (p=0.098).Conclusion: Although CVD is seen higher in the low uric acid (<7 mg/dL) group, nosignificant association was found between serum uric acid level and development of CVD instage 3-5 CKD patients, in this study. Prospective studies with larger sample sizes may providebetter evidence regarding possible relationship.
Açıklama
Anahtar Kelimeler
Kaynak
Düzce Tıp Fakültesi Dergisi
WoS Q Değeri
Scopus Q Değeri
Cilt
22
Sayı
3
